DB3, LLC (FKA THE DASCHLE GROUP)

Lobbying for REASON FOR HOPE · Nonprofit supporting suicide prevention/PTSD treatment using psychedelic-assisted therapy.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $20,000.00 income · posted Jul 17, 2026

Bills named in this filing 2

Lobbying activity 3

Law Enforcement/Crime/Criminal Justice

Freedom to Heal Act (H.R.6434/S.3346)

Health Issues

Issues related to funding for psychedelics research and psychedelic-assisted therapy

Veterans

Veterans mental health research & treatment

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.